TABLE 3

Critical care and hospital survival according to patient group and intensive care unit (ICU) therapy

NICU survivalHospital survival90-day survival1-year survivalN#5-year survival#
Overall242190 (78.5)169 (69.8)158 (65.3)132 (54.5)14645 (30.8)
Patient group
 Medical167120 (71.9)99 (59.3)91 (54.5)68 (40.7)11426 (22.8)
 Surgical5047 (94.0)47 (94.0)45 (90)42 (84)1910 (52.6)
 Obstetric2523 (92.0)23 (92.0)22 (88)22 (88)139 (69.2)
PH group
 1 PAH162127 (78.4)115 (71.0)107 (66.0)90 (55.6)9532 (33.7)
 2 PH due to left heart disease1311 (84.6)10 (76.9)10 (76.9)8 (61.5)72 (28.6)
 3 PH due to lung disease/hypoxia149 (64.3)8 (57.1)7 (50)6 (42.9)100 (0)
 4 Chronic thromboembolic PH3934 (87.2)29 (74.4)27 (69.2)24 (61.5)2610 (38.5)
 5 Unclear/multifactorial149 (64.3)7 (50)7 (50)4 (28.6)81 (12.5)
ICU therapy (medical patients only)
 CPAP as highest level of ventilatory support5334 (64.1)27 (50.9)25 (47.1)20 (37.7)332 (6.1)
 NPPV as highest level of ventilatory support159 (60)6 (40)5 (33.3)3 (20)100 (0)
 IPPV as highest level of ventilatory support93 (33.3)1 (11.1)1 (11.1)1 (11.1)90 (0)
 CRRT2217 (77.3)11 (50.0)9 (40.9)7 (31.8)205 (25)
 Vasopressors received4923 (46.9)16 (32.7)15 (30.6)11 (22.4)283 (10.7)
 Inotropes received3717 (45.9)13 (35.1)12 (32.4)7 (18.9)293 (10.3)
 Prostaglandins (intravenous) received11378 (69.0)68 (60.2)61 (54)45 (39.8)7318 (24.7)

Data are presented as n (%), unless otherwise stated. PH: pulmonary hypertension; PAH: pulmonary arterial hypertension; CPAP: continuous positive airway pressure; NPPV: non-invasive positive pressure ventilation: IPPV: invasive positive pressure ventilation; CRRT: continuous renal replacement therapy. #: patients admitted prior to 31 December 2013 for whom 5 years of survival data is available.